Introduction: Ventilator-associated pneumonia (VAP) is a distinct clinical entity characterized
by an onset after 48 hours of the application of mechanical ventilation (MV). Protocols exist …

Ventilator-associated pneumonia (VAP) is one of the most common infections in patients
who are mechanically ventilated and is frequently due to infection by antibiotic-resistant …

Background Ventilator-associated pneumonia (VAP) is one of the most frequent clinical
problems in ICU with an elevated morbidity and costs associated with it, in addition to …

Despite aggressive efforts to reduce nosocomial infections, many intubated patients develop
ventilator-associated pneumonia (VAP). VAP has been an area of intense research; …

Despite progress in the diagnosis, prevention and therapy for hospital-acquired infections,
ventilator-associated pneumonia (VAP) continues to complicate the course of a significant …

Ventilator-associated pneumonia (VAP) is the most frequent infection among patients
hospitalized in intensive care units, maintaining a high morbidity and mortality. The global …

Introduction: Although national surveillance data suggests that the incidence of ventilator
associated pneumonia (VAP) is down-trending, it remains one of the most commonly …

Ventilator-associated pneumonia (VAP) management depends on the interaction between
the infective agent, the host response, and the antimicrobial drug used. After the pathogen …

Ventilator‐associated pneumonia (VAP) is the most common infectious complication in
patients receiving mechanical ventilation and accounts for exorbitant use of resources in the …

Ventilator-associated pneumonia (VAP) is responsible for approximately half of the
infections acquired in the intensive care unit (ICU) and represents one of the principal …